Consent form to participate in the STI571 clinical trial of the targeted therapy Glivec (imatinib) in patients with Chronic Myeloid Leukaemia (CML), signed by Doreen Eggleton, 3rd October 2001. This was the copy of consent kept by the patient. Patient consent form relating to a UK clinical trial of Glivec (Imatinib), 2001 2001